Raybow has experienced personnel, a long track record and an excellent R&D technology platform for small molecule innovative drugs. We have flexible capacity for production from first batches all the way through to commercialization. As a leading enterprise in the field of global new drug Contract Development and Manufacturing Organizations (CDMOs), Raybow is committed to provide its global partners with “One-Stop Service”. We cover all stages of drug developement, from new drug pre-clinical research to commercial production and formulation. High quality, high efficiency, and high flexibility are what we are known for. Raybow is a Jiuzhou Company.